← Leaderboards
Toshiaki Kodama
Oregon Health And Science University
$2,830,017
Attributed
$2,830,017
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,830,017 · 6
By mechanism
R01$2,128,419 · 2
P51$701,598 · 4
Top collaborators
No co-investigators on record.
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Michael K Axthelm$55,327,913
- Scott W Wong$37,618,864
- Klaus J Frueh$30,512,644
- Louis J. Picker$102,909,472
- Gregory G Burrows$6,927,254
Others in their field
Top investigators on “Cytokine Receptors”
- Fulton T Crews · University Of North Carolina Chapel Hill$32,379,171
- Peter Scott Heeger · Case Western Reserve University$30,350,090
- Joshua A Boyce · Brigham And Women'S Hospital$28,932,672
- David Artis · Weill Medical Coll Of Cornell Univ$23,113,206
- Mitchell Kronenberg · Cedars-Sinai Medical Center$23,048,839
- Lionel B Ivashkiv · Hospital For Special Surgery$22,195,539
Research focus
Cytokine ReceptorsMacaca MulattaSimian Immunodeficiency VirusInflammationImmunologyCommunicable DiseasesAidsMammaliaLymphatic SystemHematologyAnimal TissueModel Design /DevelopmentVirusHuman TissueMolecular PathologyHiv Envelope Protein Gp120Helper T LymphocyteGene ExpressionCell DeathLeukocyte Activation /TransformationMhc Class I AntigenEvolutionIntermolecular InteractionEnzyme Linked Immunosorbent Assay
Grant awards (14)
Pathogenic Conversion of Attenuated SIV D nef$331,350
R01 · FY2004 · AI
Pathogenic Conversion of Attenuated SIV D nef$332,530
R01 · FY2003 · AI
Pathogenic Conversion of Attenuated SIV D nef$333,708
R01 · FY2002 · AI
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION$280,170
R01 · FY2002 · AI
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV$111,112
P51 · FY2002 · RR
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION$111,112
P51 · FY2002 · RR
Pathogenic Conversion of Attenuated SIV D nef$313,068
R01 · FY2001 · AI
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION$272,770
R01 · FY2001 · AI
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION$111,112
P51 · FY2001 · RR
MOLECULAR ANALYSIS OF THIRD VARIABLE ENVELOPE REGION OF SIV$111,112
P51 · FY2001 · RR
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION$264,623
R01 · FY2000 · AI
SIV CORECEPTOR USAGE DETERMINES CD4+ T CELL DEPLETION$128,575
P51 · FY2000 · RR
SIGNIFICANCE OF SIV CXCR4 USAGE FOR THYMIC PATHOGENICITY$128,575
P51 · FY2000 · RR
SIV CORECEPTOR USAGE DETERMINES CD4+T CELL DEPLETION$200
R01 · FY2000 · AI